Market Context — Why This Technology, Why Now

The pharmaceutical and biotechnology sectors face immense pressure to accelerate drug discovery and biomarker identification, necessitating high-throughput, high-precision analytical methods. Simultaneously, the clinical diagnostics market demands more accurate and efficient tools for disease mechanism elucidation and personalized treatment. This technology directly supports these trends by streamlining IMAS sample preparation, a critical step that often limits throughput and reproducibility. Its ability to reduce reliance on skilled labor also aligns with broader industry efforts to automate processes and mitigate workforce challenges.

Key Competitive Advantages
01

Eliminates skill dependency and reduces preparation time by ~50%

02

Completely preserves the localization of target substances for high-precision analysis

03

Enables direct IMAS application with zero signal interference from adhesive

Market Opportunity
Pharmaceutical & Biotechnology
$3B–$3.5B globally (AI est.)
High-precision spatial molecular information is crucial for identifying target molecules, analyzing pharmacokinetics, and discovering biomarkers in new drug development. This technology could significantly accelerate R&D cycles.
Major pharmaceutical R&D divisions Biotechnology companies developing new diagnostics Contract research organizations (CROs) specializing in preclinical studies
Clinical Diagnostics & Medical Devices
$1.5B–$2B globally (AI est.)
There is a growing need for accurate localization of specific molecules within tissues for pathological diagnosis and understanding disease mechanisms. This technology could enhance diagnostic accuracy and has potential applications in personalized medicine.
Medical device manufacturers for diagnostic equipment Clinical pathology laboratories Research hospitals and academic medical centers
Food & Agriculture
$650M–$1B globally (AI est.)
This technology could contribute to quality control and safety assurance in fields requiring spatial information of trace components, such as analyzing the distribution of functional ingredients or contaminants in food, and evaluating agricultural product quality.
Food safety and quality control laboratories Agricultural research institutions Companies developing functional food ingredients
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent robustly protects the core technology for preparing thin sections for imaging mass spectrometry and the associated analysis method, covering multiple aspects through four claims. Its successful grant, despite rigorous examination and limited prior art, indicates a strong, stable right with low invalidation risk, providing a solid foundation for commercial deployment.

Competitive White Space

While this patent covers the preparation and analysis of thin sections for IMAS, it does not explicitly cover novel IMAS detection methods or advanced data analysis algorithms. Licensees could develop proprietary software for 3D reconstruction or AI-driven biomarker identification without conflict.

Economic Impact
~$150K/year estimated cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Introducing this technology could reduce annual skilled labor time for IMAS thin section preparation by approximately 30%. Assuming an annual personnel cost of $200K (AI est.) for five skilled workers, this translates to an estimated annual labor cost reduction of $60K (AI est.). Additionally, reducing failure rates could save an estimated $100K (AI est.) annually in re-experiment costs (reagents, samples, equipment operation). The total estimated annual cost savings could reach ~$160K (AI est.).

Speed to Market
6× faster than in-house development
Developing this technology in-house would require at least 3 years for adhesive selection, optimization of bonding/peeling conditions, and biological sample validation. However, licensing this patent offers a fast track: the simple physical processes of 'adhesion' and 'peeling' are already well-defined and the basic technical principles are established. This allows licensees to focus on adapting the technology to existing IMAS equipment and lab environments, potentially reaching practical application within 6 months, significantly accelerating market entry.
Competitive Positioning

X: Analytical Precision & Reproducibility
Y: Preparation Simplicity & Speed

Business Models & Applications
📝 Licensing Model
Granting implementation rights to IMAS equipment manufacturers or reagent suppliers to earn royalty revenue. This model could enable rapid expansion into broad markets.
🤝 Joint Research & Development Model
Collaborating with pharmaceutical companies or university research institutions to advance applied research focused on specific disease diagnostics or drug development. This allows for deeper technological exploration and new market penetration.
🔬 Contract Analysis Service Model
Offering contract IMAS analysis services using thin sections prepared with this technology. This addresses customer needs for high-precision analysis and secures a new revenue stream.
Adjacent Application Opportunities
💊 Pharmaceutical Development
Organ-Specific Pharmacokinetic Analysis
In preclinical drug development, this technology could enable high-precision analysis of drug distribution within specific organs or tissues using IMAS. This would enhance the accuracy of efficacy evaluation and side effect prediction, potentially shortening development timelines and reducing costs by up to 20%.
🔬 Materials Science
Functional Material Surface Element Distribution
For high-performance films or catalyst surfaces, this technology could be used to prepare thin sections for IMAS analysis, revealing the localization of specific elements or molecules on micro-structured material surfaces. This application could lead to a 15% improvement in material performance and quality control.
🧪 Environmental Science
Microalgae & Microorganism Metabolite Localization
This technology could facilitate IMAS analysis of intracellular metabolite localization in microalgae and microorganisms, aiding in the development of biofuels or valuable substances. This could potentially improve biomass production efficiency by 10-25% and clarify environmental pollutant degradation mechanisms.
Integration Roadmap — Estimated 15-Month Deployment
Phase 1: Technical Feasibility Assessment
Duration: 3 months
Evaluate the technology's compatibility with the licensee's existing IMAS equipment and biological samples. Select and optimize the adhesive, and establish initial thin section preparation protocols.
Phase 2: Prototype Development & Validation
Duration: 6 months
Develop a thin section preparation prototype tailored to specific research or diagnostic applications based on the established protocol. Verify reproducibility, accuracy, and efficiency using real samples.
Phase 3: Commercialization & Market Launch
Duration: 6 months
Standardize the validated protocol and integrate it into the IMAS analysis workflow. After internal training, commence full-scale operation in R&D departments or contract analysis services, and proceed with market introduction.
Technical Feasibility
This technology primarily involves a simple adhesion and peeling process using an adhesive, demonstrating high compatibility with existing imaging mass spectrometry instruments and general laboratory equipment. The methodology described in the patent claims does not require the introduction of complex new hardware, being achievable through changes in reagents and procedures. This allows licensees to integrate it smoothly into existing analytical environments without significant capital investment, indicating a very low technical adoption barrier.
Success Scenario
Upon adopting this technology, R&D departments could potentially halve the time required for IMAS thin section preparation. This could increase the number of experiments conducted within the same period by 1.5 times, significantly improving the screening efficiency for new drug candidates. Furthermore, as high-precision sections can be prepared without skilled technicians, overall research team productivity could improve, allowing a wider range of researchers to utilize IMAS.
Patent Record
APPLICATION NO.
特願2020-182791
REGISTRATION NO.
7554465
FILING DATE
2020/10/30
GRANT DATE
2024/09/11
EXPIRATION DATE
2040/10/30
PATENT HOLDER
国立大学法人福島大学
Examination History
2023年07月18日
出願審査請求書
2024年04月02日
拒絶理由通知書
2024年06月28日
意見書
2024年06月28日
手続補正書（自発・内容）
2024年08月20日
特許査定